Company news

Island Pharmaceuticals Ltd news in 2022

Island Pharmaceuticals Ltd's news releases, calls and decks from 2022, newest first.

View company

ILA submits IND to US FDA for Phase 2a PEACH clinical trial

December 27, 2022

IRB approval received for ISLA101 Phase 2a clinical trial

December 14, 2022

ISLA101 drug product achieves stability milestone

December 14, 2022

ILA granted key Canadian patent for ISLA-101

November 15, 2022

Positive analytical results for ISLA-101 capsules

November 13, 2022

ISLA-101 manufacturing progress

October 27, 2022

ISLA-101 manufacturing and timeline update

June 15, 2022

Island executes PEACH clinical study CRO agreement

January 3, 2022

Decks in 2022